期刊文献+

功能化氧化石墨烯的制备及其介导HIF-1α基因RNA干扰的实验研究

Construction and effects of functionalized graphene oxide nonparticles-mediated RNA interference of hypoxia-inducible factor-1α gene
原文传递
导出
摘要 目的探讨功能化氧化石墨烯(GO)-聚乙二醇(PEG)-叶酸(FA)-1-芘甲胺盐酸盐(PyNH2)介导的乏氧诱导因子-1α(HIF-1α)基因的RNA干扰(RNAi)对胰腺癌Patu8988细胞生物学行为的影响。方法制备GO-PEG-FA-PyNH2载体以及介导HIF-1α基因RNAi的转染微粒(GO-PEG-FA-PyNH2-HIF-1α-RNAi),检测其转染Patu8988细胞后HIF-1α和葡萄糖转运蛋白-1(Glut-1)的表达情况,Patu8988细胞增殖、侵袭能力和细胞周期变化,以及对Patu8988细胞摄取18F-脱氧葡萄糖(FDG)的影响。多组间比较采用单因素方差分析,两两比较行最小显著差异t检验。结果成功制得GO-PEG-FA-PyNH2载体,未发现细胞毒性。乏氧或常氧状态下,GO-PEG-FA-PyNH2-HIF-1α-RNAi转染(实验组)的细胞的HIF-1α mRNA和蛋白表达以及Glut-1 mRNA表达均低于GO-PEG-FA-PyNH2(阴性组)和去血清培养基(Opti-MEM,空白组)转染的细胞(F=30.25~32.58,t=3.66~5.81,均P<0.05);实验组迁移的细胞数远少于阴性组和空白组(F=38.63和41.35,t=20.51~35.25,均P<0.01);实验组细胞增殖低于阴性组和空白组(F=35.19和38.11,t=15.11~22.19,均P<0.05);实验组G0/G1细胞比例高于阴性组和空白组(F=36.40和34.83,t=11.55~34.56;均P<0.05);实验组对18F-FDG摄取少于阴性组和空白组(F=29.85和31.69,t=3.35~4.35,均P<0.05)。结论GO-PEG-FA-PyNH2靶向介导的HIF-1α RNAi可抑制胰腺癌细胞HIF-1α的表达,导致相关生物学变化。 Objective To explore the effects of graphene oxide (GO)-polyethylene glycol (PEG)-folic acid (FA)-pyrenemethylamine hydrochloride (PyNH2)-mediated RNA interference (RNAi) of hypoxia-inducible factor-1α(HIF-1α) on the biological behaviors of human pancreatic cancer Patu8988 cells. Methods GO-PEG-FA-PyNH2 and RNAi targeting HIF-1α gene (GO-PEG-FA-PyNH2-HIF-1α-RNAi) was constructed. The expressions of HIF-1α and glucose transporter 1 (Glut-1) in Patu8988 cells were determined after knockdown of HIF-1α by RNAi. The invasive ability, the proliferation and the cell cycle of Patu8988 cells were investigated. The effect of HIF-1α knockdown on the uptake of 18F-fluorodeoxyglucose (FDG) in Patu8988 cells was also detected. Comparison of data was conducted by one-way analysis of variance and least significant difference t test. Results The GO-PEG-FA-PyNH2 was successfully constructed, and no cytotoxicity was found. Under the hypoxia or normoxia state, the mRNA and protein levels of HIF-1α and mRNA level of Glut-1 in cells transfected with GO-PEG-FA-PyNH2-HIF-1α-RNAi (study group) were lower than those in cells transfected with GO-PEG-FA-PyNH2(negative group) and cells transfected with Opti-minimal essential medium (Opti-MEM, control group;F=30.25-32.58, t=3.66-5.81, all P<0.05);the numbers of migrated cells in the study group were much lower than those in the negative group and the control group (F=38.63 and 41.35, t=20.51-35.25, all P<0.01);the cell proliferation in the study group was significantly lower than that in the negative group and the control group (F=35.19 and 38.11, t=15.11-22.19, all P<0.05). The proportions of G0/G1 cells in the study group were higher than those in the negative group and the control group (F=34.60 and 34.83, t=11.55-34.56, all P<0.05);the 18F-FDG uptake in the study group was lower than that in the negative group and control group (F=29.85 and 31.69, t=3.35-4.35, all P<0.05). Conclusion GO-PEG-FA-PyNH2-mediated HIF-1α RNAi inhibits the expression of HIF-1α in pancreatic cancer cells, leading to changes in related biological behaviors.
作者 范光磊 栾玉芬 邓胜明 万仁明 彭鸣亚 薛卫红 徐龙宝 吴翼伟 Fan Guanglei;Luan Yufen;Deng Shengming;Wan Renming;Peng Mingya;Xue Weihong;Xu Longbao;Wu Yiwei(Department of Nuclear Medicine, the First Affiliated Hospital of Soochow University, Suzhou 215006, China;Department of Nuclear Medicine, Changzhou Second People′s Hospital, Nanjing Medical University, Changzhou 213003, China;Department of Clinical Laboratory, Changzhou Second People′s Hospital, Nanjing Medical University, Changzhou 213003, China)
出处 《中华核医学与分子影像杂志》 CAS 北大核心 2019年第5期287-291,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 常州市卫生和计划生育委员会青年人才科技项目(QN201717) 南京医科大学科技发展基金(2017NJMUZD037).
关键词 胰腺肿瘤 肿瘤细胞 培养的 RNA 小分子干扰 缺氧诱导因子1 Α亚基 氧化石墨烯 聚乙烯二醇类 叶酸 1-芘甲胺 Pancreatic neoplasms Tumor cells, cultured RNA, small interfering Hypoxia-inducible factor 1, alpha subunit Graphene oxide Polyethylene glycols Folic acid 1-Pyrenemethylamine
  • 相关文献

参考文献4

二级参考文献23

  • 1Ji S, Xu J, Zhang B, el al. RGD-conjugated albumin nmmparticles as a novel delivery vehicle in pancreatic cancer therapy. Crower Biol Ther, 2012, 13: 206-215.
  • 2Koivunen P, Hitili M, Remes AM, et al. Inhibition of hypoxia- inducible factor (HIF)hydroxylases hy citric acid cycle intermedi- ates: possible links between cell metabolism and stabilization of HIF. J Blot Chem, 2007, 282: 4524-4532.
  • 3Rupp J, Gieffers J, Klinger M, et al. Chlamydia pneumoniae di- rectly interferes with HIF-lct stabilization in human host cells. Cell Microbiol, 2007, 9: 2181-2191.
  • 4Couvelard A, O'Toole D, leek R, et al. Expression of hypoxia-in- ducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic duct adenocarcinomas. Histopathology, 2005, 46: 668-676.
  • 5Gray MJ, Zhang J, Ellis LM, et al. ttlF-lalphy, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regu- lates Src-dependent hypoxia-induced expression of VEGF in pancreatic and plstate carcinomas. Oncogene, 22)05, 24: 3110-3120.
  • 6Zhang J J, Wu HS, Wang L, et al. Expression and significance of TLR4 and H1F-lct in pancreatic ductal adenocarcinoma. World J Gastroenterol, 2010, 16: 2881-2888.
  • 7Kaur B, Khwaja FW, Severson EA, et al. Hypoxia and the hypoxia- inducible-factor pathway in glioma growth and mlgiogenesis. Neuro Oncol, 2005, 7: 134-153.
  • 8Gondi CS, Rao JS. Concepts in in vivo siRNA delivery ibr cancer therapy. J Cell Physiol, 2009, 220: 285-29l.
  • 9Shib@ T, Nagao M, lkeda N, et . Prognostic significance of HIF- la overexpression in human pancreatic cancer. Anticancer Res, 2003, 23: 4721-4727.
  • 10Tan C, de Noronha RG, l.oecker A J, et al. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res, 2005, 65: 605-612.

共引文献171

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部